TrialClinical cancer research : an official journal of the American Association for Cancer Research2012

Analysis of Fcγ receptor IIIa and IIa polymorphisms: lack of correlation with outcome in trastuzumab-treated breast cancer patients.

Sara A Hurvitz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.